,

Gil Aizik1, Claire A Ostertag-Hill2, Priyadarshi Chakraborty1

  • 1Laboratory for Biomaterials and Drug Delivery, Boston Children's Hospital, Harvard Medical School, Harvard Institutes of Medicine, Boston, MA 02115, USA; Department of Anesthesiology, Critical Care, and Pain Management, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.

Acta biomaterialia
|June 4, 2024
PubMed
概括

这项研究引入了一种由自组合脂质体制成的新型可注射水凝,用于控制药物释放. 这种脂质体水凝提供可调节的释放配置文件,并改善了水友药物的体内稳定性.